Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,357 | -8,475 | -3,723 | -24,790 | -20,999 |
| Depreciation Amortization | 4 | 3 | 1 | 5 | 3 |
| Other Working Capital | -503 | -278 | -933 | 235 | 119 |
| Other Operating Activity | 1,452 | 1,002 | 285 | 3,171 | 2,568 |
| Operating Cash Flow | $-12,404 | $-7,749 | $-4,370 | $-21,380 | $-18,309 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -5 | N/A | -3 | -3 |
| Investing Cash Flow | $-5 | $-5 | $N/A | $-3 | $-3 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 24,143 | 20,754 | 20,754 | 4,897 | 4,167 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 730 |
| Financing Cash Flow | $24,143 | $20,754 | $20,754 | $4,897 | $4,897 |
| Beginning Cash Position | 20,489 | 20,489 | 20,489 | 36,975 | 36,975 |
| End Cash Position | 32,223 | 33,490 | 36,874 | 20,489 | 23,560 |
| Net Cash Flow | $11,734 | $13,001 | $16,384 | $-16,486 | $-13,415 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,404 | -7,749 | -4,370 | -21,380 | -18,309 |
| Capital Expenditure | -5 | -5 | N/A | -3 | -3 |
| Free Cash Flow | -12,409 | -7,754 | -4,370 | -21,383 | -18,312 |